Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis.

Vincent T JanmaatSophie H van OlphenKatharina E BiermannLeendert H J LooijengaMarco B BrunoManon C W Spaander

Published in: PloS one (2017)

Use of p53 IHC staining may improve risk stratification in BE surveillance. Aberrant p53 expression in BE patients appeared to be associated with a significantly increased risk of neoplastic progression for both non-dysplastic and LGD BE patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
public health
peritoneal dialysis
prognostic factors
patient reported